Foster Wayne
Insider CIK 1709769 · MRSN Vice President of Finance · AVIR See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2026-01-31 | 2026-02-03 | 108,000 | — | $0 | 108,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 8,000 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2026-01-31 | 2026-02-03 | 33,333 | — | $0 | 0 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2026-01-31 | 2026-02-03 | 41,333 | — | $0 | 91,461 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2026-01-31 | 2026-02-03 | 12,132 | $4.24 | $51.4K | 79,329 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 120,100 | — | $0 | 120,100 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2025-01-31 | 2025-02-04 | 8,000 | — | $0 | 8,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2025-01-31 | 2025-02-04 | 33,333 | — | $0 | 33,333 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | F Tax w/h | 2025-01-31 | 2025-02-04 | 12,062 | $3.06 | $36.9K | 50,128 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award | 2025-01-31 | 2025-02-04 | 8,000 | — | $0 | 62,190 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2025-01-31 | 2025-02-04 | 33,333 | — | $0 | 54,190 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | S Sale | 2024-02-01 | 2024-02-02 | 12,477 | $3.84 | $47.9K | 20,857 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2024-01-31 | 2024-02-02 | 120,100 | — | $0 | 120,100 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise deriv | 2024-01-31 | 2024-02-02 | 33,334 | — | $0 | 66,666 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | M Exercise | 2024-01-31 | 2024-02-02 | 33,334 | — | $0 | 33,334 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 140,000 | — | $0 | 140,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2022-01-31 | 2022-02-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2021-01-29 | 2021-02-01 | 71,750 | — | $0 | 71,750 | SEC↗ |
| AVIR Atea Pharmaceuticals, Inc. | A Award deriv | 2020-10-29 | 2020-10-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2019-01-23 | 2019-01-25 | 30,750 | — | $0 | 30,750 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | A Award deriv | 2018-02-02 | 2018-02-06 | 20,250 | — | $0 | 20,250 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2018-01-30 | 2018-02-01 | 889 | — | $0 | 889 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2018-01-30 | 2018-02-01 | 2,499 | — | $0 | 10,834 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2018-01-30 | 2018-02-01 | 3,262 | — | $0 | 8,155 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise deriv | 2018-01-30 | 2018-02-01 | 8,055 | — | $0 | 12,084 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2018-01-30 | 2018-02-01 | 8,055 | $1.53 | $12.3K | 65,322 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2018-01-30 | 2018-02-01 | 889 | $1.62 | $1.4K | 57,267 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2018-01-30 | 2018-02-01 | 2,499 | $6.98 | $17.4K | 71,083 | SEC↗ |
| MRSN Mersana Therapeutics, Inc. | M Exercise | 2018-01-30 | 2018-02-01 | 3,262 | $4.10 | $13.4K | 68,584 | SEC↗ |